In the movie “X-Men: The Last Stand”, the fictional pharmaceutical company, Worthington Labs, develops an inoculation to suppress the gene that gives mutants their super-powers, offering the “cure” to any mutant who desires it. The “cure” was derived from the DNA of a young child whose powers included suppressing other mutants’ abilities. Although this scenario is fictional, some pharmaceutical therapies are actually being manufactured today in the form of biologics. Some characteristics of biologics are:
Welcome to upside
For many companies, particularly in cutting-edge high technology industries, an evolution has occurred as post-sales services have become an important part of their business. Post-sales services have become a significant source of revenue and profit, a way to build long-term customer relationships, and a source of competitive advantage. As healthcare evolves, the importance of services is likely to grow, creating a corresponding need for post-sales supply chain management.
Supply chains can be thought of in three categories:
Flying pretty much anywhere these days is expensive. And it’s almost twice as expensive when I travel with my daughter.
And the reason is simple: The route from airport security to the departure gate is littered with opportunities to spend money. There are stores that sell expensive clothes, jewelry, electronics, duty-free goods, food and tacky tee-shirts that announce to the world that the wearer has spent time in the City of Atlanta. (The “I’m a Georgia Peach” key ring complements the tee shirt nicely, by the way.)
Traveling to see family in China once, my daughter and I had too much time to kill in the airport. And, like a wasp to blueberry jelly, she was immediately drawn to the most expensive items for sale in the retail area.
How can I create business advantage with my supply chain? This is a question healthcare companies are increasingly asking themselves, and their logistics service providers, as the market becomes more competitive, more global, and frankly more challenging. Healthcare companies are recognizing that their supply chain’s performance can have a significant impact on their overall performance and are a source of competitive advantage.
UPS recently launched our 6th annual UPS Pain in the (Supply) Chain survey, which takes the pulse of healthcare logistics executives around the world on their top business and supply chain concerns and “pain points,” successful strategies they have put in place to address issues and future investment plans.
This post focuses on top findings in Western Europe, where executives are seeing success in strategies they have put in place to address regulatory compliance issues and are planning further investments, even in a difficult economic environment.
UPS marks its 6th “Pain in the (Supply) Chain survey” this year, which is conducted annually across North America, Western Europe, Asia Pacific (interactive executive summary) and Latin America. This week, we focus on the findings from the Asia Pacific region where healthcare logistics executives are particularly concerned about product protection, which include both product security and product spoilage.
Ensuring the security and traceability of healthcare shipments is of growing importance, especially as the counterfeiting of healthcare products continues to rise. An important step is for the U.S. to adopt legislation that creates uniform national standards and enforcement for serialization and licensing (to preempt a patchwork of state-level regulations). While it has been a slow process, progress is being made on the legislative front.
In thinking about policy, especially at the federal level, it is important to focus on: “What problem are we trying to solve?” In this situation, it is ensuring access to safe medicines and preventing counterfeit drugs from reaching consumers.
Today, we are releasing our 6th annual UPS Pain in the (Supply) Chain survey, conducted by the research firm TNS. The survey reveals insights into the top challenges facing global healthcare logistics executives and highlights their future investment plans. This year we added new geographies to the survey and probed deeper to uncover strategies that successful healthcare executives are implementing to overcome their top supply chain challenges.
Fortune favors the prepared mind
– Louis Pasteur
The concept of disease was first introduced by Hippocrates more than two thousand years ago . 1. Hundreds of years later, pioneers like Louis Pasteur and Robert Koch demonstrated to the world how a microscope can identify of the causes of diseases. Today, Clinical Lab is a $50 billion industry in the United States alone and medical diagnostic testing influences 70% of all healthcare treatment decisions .
The 21st century Clinical Lab exemplifies the rapid pace of implementing advances in technology and science to facilitate the efficient and accurate diagnosis of medical conditions. For example, tests which were unimaginable a few years ago, are routinely completed in just a few hours today.
Surprisingly, one of the biggest challenges in healthcare over the past five years has been a shortage of pharmaceuticals. From 2006 to 2011 drug shortages grew by 400%. It is now a common practice for hospital pharmacies to maintain lists of which pharmaceuticals are available for physicians to prescribe.